Neuronetics (STIM) Net Income towards Common Stockholders (2017 - 2026)
Neuronetics (STIM) reported Net Income towards Common Stockholders of -$11.3 million for Q1 2026, up 11.43% year-over-year from -$10.1 million in Q1 2025, and down 41.51% quarter-over-quarter from -$8.0 million in Q4 2025.
Neuronetics (STIM) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Net Income towards Common Stockholders data on file, last reported at -$11.3 million in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$11.3 million, up 11.43% year-over-year; the trailing twelve-month figure through Mar 2026 was -$38.8 million (up 15.26% YoY), and the FY2025 annual result was -$39.9 million, up 4.77% from the prior year.
- Net Income towards Common Stockholders slipped to -$11.3 million in Q1 2026 per STIM's latest filing, from -$8.0 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$6.3 million in Q4 2023 and troughed at -$13.2 million in Q4 2024.
- A 5-year average of -$9.9 million and a median of -$10.0 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders tumbled 110.96% in 2024, then jumped 39.84% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$8.8 million in 2022, then increased by 28.96% to -$6.3 million in 2023, then plunged by 110.96% to -$13.2 million in 2024, then surged by 39.84% to -$8.0 million in 2025, then slumped by 41.51% to -$11.3 million in 2026.
- Business Quant data shows STIM's Net Income towards Common Stockholders at -$11.3 million in Q1 2026, -$8.0 million in Q4 2025, and -$9.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Neuronetics | 2.61 Mn | -7.06 Mn | 16.15 Mn | -11.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.26 Mn |
| Dec 31, 2025 | -7.96 Mn |
| Sep 30, 2025 | -9.53 Mn |
| Jun 30, 2025 | -10.03 Mn |
| Mar 31, 2025 | -12.71 Mn |
| Dec 31, 2024 | -13.23 Mn |
| Sep 30, 2024 | -9.33 Mn |
| Jun 30, 2024 | -10.49 Mn |
| Mar 31, 2024 | -8.69 Mn |
| Dec 31, 2023 | -6.27 Mn |
| Sep 30, 2023 | -10.06 Mn |
| Jun 30, 2023 | -8.49 Mn |
| Mar 31, 2023 | -11.01 Mn |
| Dec 31, 2022 | -8.83 Mn |
| Sep 30, 2022 | -8.35 Mn |
| Jun 30, 2022 | -10.60 Mn |
| Mar 31, 2022 | -11.11 Mn |
| Dec 31, 2021 | -7.97 Mn |
| Sep 30, 2021 | -8.18 Mn |
| Jun 30, 2021 | -7.54 Mn |